source
- Cytokinetics' HCM drug shows positive trial results, potentially doubling market after Bristol Myers' setbackCytokinetics announced that its oral therapy for hypertrophic cardiomyopathy (HCM) achieved positive results in a pivotal trial targeting a different form of the disease. The data suggest the drug…
- Pharma's reputation among patient groups edges up to 57% but access and pricing concerns lingerPatient groups surveyed by research firm PatientView gave drugmakers a 57% “good” or “excellent” reputation rating, the highest level since 2023. The survey covered more than 2,400 groups in 35 cou…